Evidence map›Paper›PMID 42488184›Full record

ArticleIranian journal of pharmaceutical research : IJPR

The Impact of Marijuana (

Hossein Kargar Jahromi, Vida Khalafi, Vida Mirzaei, Faezeh Ebrahimi-Zadeh, Pouria Azami, Tara Abdolahy, Iman Razeghian-Jahromi

Abstract read
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hossein Kargar JahromiResearch Center for Noncommunicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran.ORCID https://orcid.org/0000-0002-2614-8885
Vida KhalafiStudent Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.ORCID https://orcid.org/0000-0001-8137-786X
Vida MirzaeiDepartment of Cardiology, Shiraz University of Medical Sciences, Shiraz, Iran.
Faezeh Ebrahimi-ZadehStudent Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.
Pouria AzamiCardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Tara AbdolahyCardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Iman Razeghian-JahromiCardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID https://orcid.org/0000-0001-8137-786X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Objectives: This study aimed to investigate the effects of Methods: Human cardiomyocytes (HCMs) were cultured and subsequently exposed to varying concentrations of cannabis extract. Cell viability was assessed using the MTT assay, and morphological changes were examined on days 3 and 6. Growth curves and population doubling times were determined over a 6-day period using the trypan blue exclusion method. In addition, the expression levels of cardiac-specific markers, including GATA4, troponin, and creatine kinase, were quantified using real-time polymerase chain reaction on days 1, 3, and 6. Results: No significant changes in cell morphology were observed; however, cell density was consistently higher in the treated group, particularly at early time points. Growth-curve analysis confirmed these findings, demonstrating higher cell numbers in treated cultures throughout the study period, consistent with the population doubling time data (74.79 h in the treated group vs. 80.45 h in the control group, P = 0.005). Furthermore, the treated group exhibited increased expression of cardiac-specific markers compared with the controls, most notably between day 1 and day 3 (GATA4: 7.97 ± 1.06 vs. 1.48 ± 0.64, P < 0.05; troponin: 3.52 ± 0.85 vs. 1.13 ± 0.92, P = 0.05; creatine kinase: 0.001 ± 0.0008 vs. 1.22 ± 0.90, P = 0.05). Conclusions:

Indexed as

Cannabis sativaCardiac BiomarkersHuman CardiomyocytesMarijuanaViability

Identifiers

PMID42488184
PMCPMC13389378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.